The Kitasato Institute
102Patents
35Active
102Granted
47Portfolio score
Filing activity: Mar 20, 1974 → Dec 29, 2020 · 12 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5182109A | Vaccine preparation comprising a bacterial toxin adjuvant | Emerging Cross-Sectional Technologies | 79 | Expired |
| US6734292B1 | Pseudoerythromycin derivatives | Human Necessities | 25 | Expired |
| US4985244A | Stabilized live attenuated vaccine and its production | Chemistry; Metallurgy | 22 | Expired |
| US4107297A | Antibiotic compound | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5807721A | Compound FO-1289, process of production with aspergillus and strain | Emerging Cross-Sectional Technologies | 18 | Expired |
| US4469685A | Process for producing interferon inducers | Human Necessities | 18 | Expired |
| US4533548A | Acidic polysaccharide CH-1 isolated from Chlorella pyrenoidosa and the use thereof | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5654136A | Attenuated measles virus vaccine, containing specific nucleotide sequence and a method for its absolute identification | Chemistry; Metallurgy | 13 | Expired |
| US6605595B1 | Avermectin derivatives | Human Necessities | 13 | Expired |
| US4421746A | Process for producing interferon inducers | Human Necessities | 13 | Expired |
| US7630836B2 | Polynucleotides | Chemistry; Metallurgy | 13 | Expired |
| US6512099B2 | Roselipin derivative | Chemistry; Metallurgy | 12 | Expired |
| US6608185B1 | Substances KF-1040T4A,KF-1040T4B, KF-1040T5A, and KF-1040T5B, and process for producing same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9579273B2 | Delivery of therapeutic agents by a collagen binding protein | Emerging Cross-Sectional Technologies | 8 | Active |
| US9526765B2 | Delivery of therapeutic agents by a collagen binding protein | Chemistry; Metallurgy | 8 | Active |
| US4157389A | Mixed vaccine against infections by pseudomonas aeruginosa | Human Necessities | 7 | Expired |
| US7250402B2 | Avermectin derivatives | Chemistry; Metallurgy | 7 | Expired |
| US5672693A | Glycosphingolipids | Chemistry; Metallurgy | 7 | Expired |
| US4770875A | Process for preparation of improved mutant strain of Bordetella bronchiseptica useful for live attenuated vaccine for protection of B. bronchiseptica infection and live attenuated AR vaccine produced therefrom | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4419349A | Interferon inducer, a process for producing the same and pharmaceutical composition containing the same | Human Necessities | 6 | Expired |
| US4226879A | Antibiotic composition | Human Necessities | 6 | Expired |
| US4456597A | Interferon inducer, a process for producing the same and pharmaceutical composition containing the same | Human Necessities | 6 | Expired |
| US6077943A | Method of producing erythromycin derivative | Chemistry; Metallurgy | 6 | Expired |
| US8952030B2 | Morphinan derivative | Chemistry; Metallurgy | 6 | Active |
| US4442087A | Interferon inducer, a process for producing the same and pharmaceutical composition containing the same | Human Necessities | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.